Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

Acute graft-versus-host disease (aGvHD) is the major barrier to the broader use of allogenetic hematopoietic stem cells. However, currently these are no highly specific and efficient drugs. Monotherapy is not sufficient and more efficient and safe therapeutic regimen are urgent need. Studies demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Huijie, Zhao, Tiesuo, Ji, Yinghua, Jia, Xiaolong, Ren, Wenjing, Li, Chen, Li, Minming, Xiao, Yali, Wang, Hui, Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261008/
https://www.ncbi.nlm.nih.gov/pubmed/27906171
http://dx.doi.org/10.1038/cddis.2016.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261008/
https://www.ncbi.nlm.nih.gov/pubmed/27906171
http://dx.doi.org/10.1038/cddis.2016.399

Ejemplares similares